No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Biotechnology
Established in 1997 and headquartered in Yucheng, China, Baolingbao Biology Co.,Ltd. specializes in the production of a wide array of corn-based ingredients for health and food industries, serving both domestic and international markets. Its diverse product range includes various oligosaccharides like isomalto-oligosaccharide, galacto-oligosaccharides, and fructose-oligosaccharides, as well as erythritol. The company also provides a selection of sweeteners such as high fructose corn syrups, crystalline fructose, and sugar alcohols. Furthermore, it offers specialized fibers like resistant dextrin-soluble corn fiber and polydextrose, alongside starch sugars including trehalose, maltodextrin, and glucose syrup. Completing its portfolio are certain finished goods and valuable corn by-products like corn steep liquors, corn husk sprayed products, and corn gluten meal. These versatile ingredients are widely utilized across numerous applications, from beverages, dairy, bakery, confectionery, meat, honey, seafood, canned foods, and condiments, to health foods, infant nutrition, fermentation, and animal feed. Beyond the food sector, their applications extend to daily chemicals, pharmaceuticals, and cosmetics.
www.blb-cn.comNo one on the platform currently holds 002286.SZ.
No tracked institution reports a position in 002286.SZ as of their last filing.
No one on the platform has traded 002286.SZ yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Consensus does not cover every selected forecast year. Later assumptions are extrapolated from available analyst estimates.
| Metric | Historical average | My assumptions | ||||
|---|---|---|---|---|---|---|
| 1 year | 5 years | 10 years | Low | Mid | High | |
| ROIC % | 7.3% | — | — | — | ||
| Rev. Growth % | 14.5% | 6.0% | ||||
| Profit Margin % | 5.5% | 4.9% | 3.8% | |||
| Free Cash Flow Margin % | 2.5% | |||||
| Exit P/E | — | — | — | |||
| Exit P/FCF | — | — | — | |||
| Desired Annual Return % | — | — | — | |||
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $3.0B | +19.1% | $0.44 | $0.44–$0.44 | — | 1 |
| 2027 | $3.3B | +9.0% | $0.50 | $0.50–$0.50 | — | 1 |
| 2028 | $3.6B | +8.6% | $0.59 | $0.59–$0.59 | — | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| 002286.SZBaolingbao Biology Co.,Ltd. | $7.69 | +0.26% | $2.9B | — |
| 300653.SZYantai Zhenghai Biotechnology Co., Ltd. | $14.58 | +0.55% | $2.6B | — |
| 300871.SZHvsen Biotechnology Co., Ltd. | $21.56 | +1.13% | $4.4B | — |
| 300878.SZZhejiang Wecome Pharmaceutical Company Limited | $31.89 | +1.24% | $4.5B | — |
| 603718.SSShanghai Hile Bio-Technology Co., Ltd. |
| $3.01 |
| +0.67% |
| $2.0B |
| — |
| 603739.SSQingdao Vland Biotech Inc. | $12.13 | -0.90% | $3.1B | — |
| 603896.SSZhejiang Shouxiangu Pharmaceutical Co., Ltd. | $14.03 | -0.36% | $2.8B | — |
Source: Financial Modeling Prep · peers by sector/industry